Stay updated on Repotrectinib in Rearranged Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Repotrectinib in Rearranged Solid Tumors Clinical Trial page.

Latest updates to the Repotrectinib in Rearranged Solid Tumors Clinical Trial page
- CheckyesterdayChange DetectedAdded a government funding lapse notice with status guidance and links to cc.nih.gov and opm.gov. Updated the page revision to v3.4.1.SummaryDifference0.3%

- Check8 days agoChange DetectedUI improvements to the record history page include a glossary display option, color-coded change indicators, and an updated revision tag (v3.4.0), with minor capitalization adjustments for FEAR Act text.SummaryDifference0.3%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed from the history.SummaryDifference0.0%

- Check44 days agoChange DetectedRevision: v3.3.3 was added to the history; the HHS Vulnerability Disclosure link and Revision: v3.3.2 were removed.SummaryDifference0.1%

- Check73 days agoChange DetectedFooter revision metadata updated from v3.2.0 to v3.3.2; no substantive content or functionality changes observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check80 days agoChange DetectedRemoved the government funding notice banner that previously appeared on the page.SummaryDifference0.2%

Stay in the know with updates to Repotrectinib in Rearranged Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Repotrectinib in Rearranged Solid Tumors Clinical Trial page.